person

Manon B.

Country
The Netherlands
Department
Neonatalogy

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
1
Sites with multiple studies

Has run more than one trial at 1 of 3 partner sites.

Specializations

Neonatal medicine and perinatal care

Clinical research activity in neonatology with attention to conditions affecting newborns and very early life, including apnea of prematurity, brain injury in neonates, hypoxic-ischemic encephalopathy, and chronic lung disease in extremely premature infants.

  • Preterm infant respiratory support
  • Neonatal brain injury
  • Congenital heart disease in newborns
  • Perinatal ischemic injury

Research interests also include neonatal complications linked to prematurity and early developmental vulnerability.

Pediatric and developmental disorders

Active involvement in therapeutic studies for childhood conditions such as acute lymphoblastic leukaemia, spinal muscular atrophy, osteogenesis imperfecta, mucopolysaccharidosis type I, and primary immunodeficiency diseases.

  • Childhood hematologic malignancies
  • Inherited neuromuscular disease
  • Rare skeletal disorders
  • Inborn errors of metabolism

Therapeutic focus extends to pediatric populations requiring specialized long-term disease management.

Maternal-fetal and pregnancy-related conditions

Clinical trial involvement spans hypertensive disorders of pregnancy, preterm preeclampsia, HELLP syndrome, and pregnancy in HIV infection, reflecting interest in conditions that affect maternal and fetal outcomes.

  • Pregnancy complications
  • Maternal hypertension
  • Fetal and neonatal risk reduction
  • Antiretroviral pharmacokinetics in pregnancy

Work in this area also includes disorders with direct implications for delivery planning and newborn health.

Immune-mediated and inflammatory disease

Research activity includes treatment-focused studies in atopic dermatitis, food allergy, Crohn’s disease, ulcerative colitis, juvenile idiopathic arthritis, and systemic lupus erythematosus.

  • Allergic disease
  • Inflammatory bowel disease
  • Autoimmune rheumatic disease
  • Immune dysregulation

The therapeutic landscape also covers rare immune-mediated disorders and chronic inflammatory syndromes.

Long-term safety and innovative therapies

Investigator activity includes follow-up and treatment evaluation in gene-modified T-cell therapies, CAR T-cell approaches, and other advanced interventions, with attention to safety monitoring and sustained clinical benefit.

  • Cell-based immunotherapy
  • Gene therapy follow-up
  • Rare disease treatment innovation
  • Paediatric treatment safety

Additional involvement includes therapies for severe respiratory, cardiovascular, and metabolic conditions in vulnerable patient groups.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.